The Leadership Team at Delix Therapeutics is responsible for steering the company’s strategic vision and operational execution in developing innovative, non-hallucinogenic psychedelic therapies. Comprising executives from diverse backgrounds, including scientific research, corporate governance, and human resources, the team collaborates to drive progress through preclinical and clinical stages, ensuring alignment with regulatory standards while fostering a culture of innovation and ethical responsibility in addressing mental health challenges.
View all